EE136 Cost-Effectiveness Analysis of Tisagenlecleucel Using Long-Term Survival Outcomes in Treating Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma from US Societal Perspective

Autor:	J Choe, H Abdel-Azim, M Abou-el-Enein, W Padula
Rok vydání:	2022
Předmět:	Health Policy Public Health Environmental and Occupational Health
Zdroj:	Value in Health. 25:S361
ISSN:	1098-3015
DOI:	10.1016/j.jval.2022.04.386
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::0421b830b772e5ff92b32f278f82ed40 https://doi.org/10.1016/j.jval.2022.04.386 Zobrazit plný text záznamu Full Text from ScienceDirect